Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Rhea-AI Summary

Renuvion, manufactured by Apyx Medical (NASDAQ: APYX), has won the 2025 NewBeauty Award for 'Best Minimally Invasive Skin Tightener.' The technology is the first and only FDA-cleared device for use after liposuction in body contouring treatments.

The recognition comes as consumer searches for 'sagging skin' increased by 168.7% in 2024. Renuvion's effectiveness is backed by over 90 evidence-based clinical publications, delivering long-lasting results from a single treatment. The technology combines helium plasma and radiofrequency platform technology for skin tightening and has gained widespread acceptance among plastic surgeons and consumers globally.

According to an independent survey by Wakefield Research, 4 out of 5 board-certified or eligible cosmetic and plastic surgeons in the US consider Renuvion the #1 trusted body contouring technology. The NewBeauty Awards, a leading beauty industry program, selected winners after extensive testing and consultation with board-certified doctors and medical experts.

Renuvion is the first and only body contouring technology that empowers consumers to feel and look their best, from the inside out by treating loose skin

CLEARWATER, Fla., March 25, 2025 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ: APYX) ("Apyx Medical" or the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, announced today that Renuvion has been named this year's NewBeauty Award winner in the "Best Minimally Invasive Skin Tightener"¹ category. The NewBeauty Awards franchise is a leading and trusted program in the beauty space. The award winners represent effective solutions to consumers' biggest beauty interests, concerns, and trends.

Renuvion is the only device FDA-cleared for use after liposuction and is raising the bar for what consumers should expect from body contouring treatments. With more than 90 evidence-based clinical publications and long-lasting durable results from just one treatment, Renuvion has garnered a global fan base of consumers and plastic surgeons alike. This recognition comes at a pivotal time as consumers increasingly focus on the issue of loose and lax skin. According to Spate research, searches for "sagging skin" have surged by 168.7% in 2024 compared to the previous year.²

"We are proud to have Renuvion's game-changing technology receive this accolade by a trusted authority in the aesthetic space," said Charlie Goodwin, President, and CEO of Apyx Medical. "Thousands of plastic surgeons rely on Renuvion, the #1 body contouring technology trusted by doctors³, to provide an effective solution to the challenges of loose skin."

NewBeauty editors tested thousands of products leading up to the 15^th annual Awards Issue with the goal of selecting the most innovative beauty products, treatments, and trends. NewBeauty editors also collaborate with board-certified doctors and medical experts to determine the most effective, results-driven in-office treatments and post-procedure essentials.

To learn more about how Renuvion can address skin concerns, and find a provider near you, visit www.Renuvion.com.

1. Renuvion is intended for the delivery of radiofrequency energy and/or helium plasma where coagulation/contraction of soft tissue is needed. Soft tissue includes subcutaneous tissue. Renuvion is intended for the coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring.
2. https://www.personalcareinsights.com/news/spate-search-data-suggests-innovative-opportunities-to-target-saggy-skin-and-nose-bumps.html
3. In an independent survey by Wakefield Research of 200 unaffiliated board certified or eligible cosmetic and plastic surgeons in the US where 4 out of 5 surgeons agree.

About Apyx Medical Corporation:

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical publications. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com 

Media Contact: 
Kaplow Communications 
Renuvion@kaplow.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/renuvion-wins-2025-newbeauty-award-for-best-minimally-invasive-skin-tightener-302409524.html

SOURCE Renuvion

FAQ

What makes Renuvion's 2025 NewBeauty Award significant for APYX investors?

The award validates Renuvion's market leadership in minimally invasive skin tightening, potentially strengthening APYX's market position and investor confidence in the technology's commercial success.

How has the demand for Renuvion's skin tightening technology changed in 2024?

Consumer interest has significantly increased, with searches for 'sagging skin' rising 168.7% in 2024 compared to the previous year, indicating growing market potential.

What clinical evidence supports Renuvion's effectiveness in 2025?

Renuvion is supported by over 90 evidence-based clinical publications, demonstrating long-lasting results from a single treatment.

What percentage of US plastic surgeons trust Renuvion for body contouring in 2025?

According to a Wakefield Research survey, 80% (4 out of 5) of board-certified or eligible cosmetic and plastic surgeons consider Renuvion the #1 trusted body contouring technology.

What unique FDA clearance does Renuvion have for body contouring?

Renuvion is the only device FDA-cleared specifically for use after liposuction in body contouring treatments.